Isoflurane therapy for severe refractory status asthmaticus in children

Venkat Shankar1, Kevin B Churchwell, Jayant K Deshpande

  • 1Monroe Carrell Jr. Children's Hospital at Vanderbilt, Division of Pediatric Critical Care Medicine, 5121 B Doctor's Office Tower, TN 37232-9075, Nashville, Tennessee, USA. venkat.shankar@vanderbilt.edu

Insights

Inhaled isoflurane improved blood gases and aided ventilation weaning in children with severe asthma. While generally effective, hypotension was a notable side effect requiring management.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Medicine
  • Anesthesiology

Background:

  • Life-threatening asthma in children presents significant management challenges.
  • Mechanical ventilation is often required for severe asthma exacerbations.
  • Limited treatment options exist for refractory status asthmaticus.

Purpose of the Study:

  • To evaluate the efficacy and safety of inhaled isoflurane in pediatric patients with severe asthma.
  • To describe the physiological effects of isoflurane in mechanically ventilated children.

Main Methods:

  • Retrospective case series conducted in a pediatric intensive care unit.
  • Involved 10 children (ages 1-16 years) with 11 episodes of severe asthma requiring mechanical ventilation.
  • Analyzed physiological parameters and clinical outcomes following inhaled isoflurane administration.

Main Results:

  • Isoflurane administration improved arterial pH and reduced PaCO2 in all 11 episodes.
  • Sustained clinical improvement and successful weaning from mechanical ventilation occurred in 10 cases.
  • Hypotension was observed in 8 children, requiring vasopressor support; one patient died from prior anoxic injury.

Conclusions:

  • Inhaled isoflurane is an effective treatment for improving gas exchange in mechanically ventilated children with life-threatening status asthmaticus.
  • Isoflurane offers a potential therapeutic option for severe asthma refractory to conventional management.
  • Careful monitoring for side effects like hypotension is crucial during isoflurane therapy.
Abstract

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...